March 10, 2014 11:09 pm | Updated November 16, 2021 06:33 pm IST - MUMBAI:
GlaxoSmithKline plc, on Monday, said it had successfully increased its stake in its publicly-listed Indian pharmaceuticals subsidiary GlaxoSmithKline Pharmaceuticals Ltd. from 50.7 per cent to 75 per cent.
This was done by a voluntary open offer made by its subsidiary GlaxoSmithKline Pte. Ltd., a statement from GSK said.
The offer of Rs.3,100 per share values the transaction at about Rs.6,400 crore, and the final payment for shares tendered and accepted will be completed on or before March 20.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
